Lactalis acquires Aspen’s infant-formula unit for $860m to tap Chinese market

Mother feeding baby. Photo: Tanaphong Toochinda/unsplash

Lactalis International agreed to buy an infant-formula business from Aspen Pharmacare Holdings Ltd for 739.8 million euros ($860 million) as the French dairy group targets the fast-growing Chinese market.

Continue reading this story with a subscription to DealStreetAsia.


Should your colleagues be reading this article too? Contact us for corporate subscriptions at